Nitric oxide in primary headaches

Current Opinion in Neurology

Volumn 14, Issue 3, 2001, Pages 315-321

  Thomsen, Lars Lykke ^a   Olesen, Jes ^b  

^a Lundbeck Institute   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; HISTAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

CLINICAL TRIAL; CLUSTER HEADACHE; DRUG EFFICACY; HEADACHE; HUMAN; MIGRAINE; NERVE ENDING; NONHUMAN; REVIEW; TENSION HEADACHE; VASCULAR ENDOTHELIUM;

ENZYME INHIBITORS; HEADACHE; HUMANS; MIGRAINE DISORDERS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0034987791     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200106000-00009     Document Type: Review

References (69)

1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society
2. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
3. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
4. Nitric oxide synthases in mammals
5. Involvement of nitric oxide in endothelium-dependent, phasic relaxation caused by histamine in monkey cerebral arteries
6. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
7. Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors
8. Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide
9. Mechanism underlying responses to histamine of isolated monkey and human cerebral arteries
10. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein
11. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells
12. Nitric oxide: Physiology, pathophysiology, and pharmacology
13. Regulation of nitric oxide synthase and soluble guanylyl cyclase
14. Reciprocal regulation by putatively nitroxidergic and adrenergic nerves of monkey and dog temporal arterial tone
15. Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries
16. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
17. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles
18. Endogenous nitric oxide synthesis: Biological functions and pathophysiology
19. Some observations on headache
20. Experimental studies on headache. Pain sensitive structures in the head and their significance in headache
21. Unmasking latent dysnociception in healthy subjects
22. Cluster headache: Transcranial Doppler ultrasound and rCBF studies
23. Nitric oxide-induced headache in patients with chronic tension-type headache
24. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite
25. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
26. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics
27. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate
28. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs
29. N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses
30. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms
31. Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain
32. A nitric oxide donor (nitroglycerine) triggers genuine migraine attacks
33. Glyceryl trinitrate induced headache in migraineurs: Relation to attack frequency
34. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura
35. Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat
36. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers
37. Haemodynamic correlates of early and delayed responses to sublingual administration of isosorbide dinitrate in migraine patients: A transcranial Doppler study
38. Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: A possible link with the NO pathway
39. Platelet nitric oxide metabolites in migraine
40. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura
41. Nitric oxide, endothelin-1, and transcranial Doppler in migraine. Findings in interictal conditions and during migraine attack
42. Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients
43. Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine
44. The nitric oxide hypothesis of migraine and other vascular headaches
45. Migraine, polycythemia and chronic mountain sickness
46. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions
47. The effect of infused prostacyclin in migraine and cluster headache
48. 5-Hydroxytryptamine and its role in migraine
49. Central 5-hydroxytryptamine supersensitivity in migraine
50. The 5-hydroxytryptamine-nitric oxide connection: The key link in the initiation of migraine?
51. Activation of meningeal 5-HT2B receptors: An early step in the generation of migraine headache?
52. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: New perspectives
53. Nitric oxide synthase inhibition in migraine
54. Fos expression in the trigeminocervical complex of the cat affer stimulation of the superior sagittal sinus is reduced by L-NAME
55. SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat
56. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan
57. Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine action for sumatriptan?
58. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression
59. Effect of a nitric oxide donor on nitroxergic nerve fibers in the rat dura mater
60. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
61. Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism
62. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries
63. Hyposerotonin-induced nitric oxide supersensitivity in the cerebral microcirculation
64. Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries
65. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: A randomised crossover trial
66. Extracranial vascular responses to sublingual nitroglycerin and oxygen inhalation in cluster headache patients
67. Induction of nitrate tolerance is not a useful treatment in cluster headache
68. Histamine cephalagia